Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Gut. 2012 May 22;62(8):1153–1159. doi: 10.1136/gutjnl-2012-302362

Table 5.

Oral contraceptive use and risk of Crohn's disease according to strata of age, smoking and body mass index

Never Ever Pinteraction
Age ≤40 years 0.09
 No of cases/person-years 34/610188 154/2 079 577
 Age-adjusted HR, 95% CI 1.00 1.18 (0.81 to 1.73)
 Multivariate-adjusted HR, 95% CI* 1.00 1.09 (0.74 to 1.61)
Age >40 years
 No of cases/person-years 62/1 449 807 65/890624
 Age-adjusted HR, 95% CI 1.00 1.89 (1.29 to 2.75)
 Multivariate-adjusted HR, 95% CI* 1.00 1.73 (1.18 to 2.53)
Never smoking 0.72
 No of cases/person-years 42/1 012 745 100/1 571 377
 Age-adjusted HR, 95% CI 1.00 1.20 (0.79 to 1.83)
 Multivariate-adjusted HR, 95% CI* 1.00 1.17 (0.76 to 1.78)
Past/current smoking
 No of cases/person-years 54/1 047 250 1 19/1 398 823
 Age-adjusted HR, 95% CI 1.00 1.76 (1.22 to 2.55)
 Multivariate-adjusted HR, 95% CI* 1.00 1.65 (1.14 to 2.40)
Body mass index <25 kg/m2 0.08
 No of cases/person-years 71/1 385 147 154/2 180 254
 Age-adjusted HR, 95% CI 1.00 1.39 (1.00 to 1.92)
 Multivariate-adjusted HR, 95% CI* 1.00 1.26 (0.91 to 1.75)
Body mass index ≥25 kg/m2
 No of cases/person-years 25/674 848 65/789 947
 Age-adjusted HR, 95% CI 1.00 1.91 (1.11 to 3.31)
 Multivariate-adjusted HR, 95% CI* 1.00 1.89 (1.08 to 3.28)
*

Models adjusted for age (months), cohort (NHS I, NHS II), smoking (never, past, current), body mass index (<20, 20—24.9, 25—29.9, ≥30 kg/m2), oral contraceptive use (never, past, current), parity (nulliparous, parous), age at menarche (≤10, 11, 12, 13, ≥14 years), hormonal replacement therapy (never, past, current) and menopause status (pre-menopause, natural menopause, surgical/radiation menopause), cohort (NHS I, NHS II) and questionnaire cycle. Models were adjusted for these covariates minus the strata variable (age, smoking and body mass index).